The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy
The Drug and Device blog has an interesting post today on rulings on some unusual motions in limine in a drug case. The issues include a ruling on emails among members of an advisory panel, and whether they are admissions of the company.
The litigation industry continues to evolve and grow. Consider, for example, this June 19, 2019 press release by a group of firms brining opioid suits, titled: “Lawsuits Filed by Opioid Justice Team
For those litigating drug cases, the NEJM just published an open access article with a broad set of data on medical marketing. It’s online here at NEJM. The abstract is pasted below. ________________
A cogent summary of statutes of repose for drugs and devices is online at a July 16, 2018 guest post at Drug & Device blog.